中医药治疗甲流疗效确切市府7000万购200万人份储备中药


中医药治疗甲流疗效确切市府7000万购200万人份储备中药

 
 
 
 
 

中医药治疗甲流疗效确切市府7000万购200万人份储备中药

http://www.sina.com.cn  2009年09月18日13:10  北京晚报

  关春芳 魏强 刘燕玲/文

中医药治疗甲流疗效确切市府7000万购200万人份储备中药
 

 

  本报讯直面甲型H1N1流感在全球爆发的疫情,面对治疗药储备不足和西药毒副作用大、耐药性高等世界难题,历经3个月由市财政投入1000万元立项,市卫生局、中医局牵头,由中国中医科学院、中国医学科学院、北京工业大学、国家防治甲型H1N1流感专家组组成的中医药基础和临床小组,在全球率先从基础研究和临床研究两方面证实了中医药防治甲型H1N1流感的有效性和安全性,并筛选研制有效中药,提出了中西结合防治方案。

  昨日该课题宣布研究取得阶段性成果——中医药对肺炎有显著保护作用,对甲流高热有解热作用,对多毒株所致肺炎有疗效。根据科研初步效果,北京市政府已决定调整政府防控甲型H1N1流感药品储备目录,市政府投入7000万元,将原储备计划中的100万人份达菲原料药储备调整为200万人份相关中成药储备。

  北京市中医管理局局长赵静说:

  以科学向世界证实

  中医药能抗疫

  我市整合首都最强的中医、西医、医药和动物实验科技资源,经过近三个月探索中医药防治甲型H1N1流感的努力,目前项目取得了阶段性结果,为应对大流行,开展科学的中医药预防,进行科学合理的中药储备,轻症患者居家中医药治疗,重症患者中西结合治疗,保证首都疫情高峰来得晚一点,疫情变化引起的社会震荡小一点,重症患者和死亡病例少一点,赶在可能的流感大流行爆发前,能够以科学的数据向全世界证实中医药防治甲型H1N1流感是安全有效的,提供了科学依据。

  中医临床和科研得出的初步结果,为应对秋冬季流感大流行做好中药饮片和中成药储备提供了科学依据。我们为应对可能出现流感病毒变异和流感大流行,为应用便宜、安全、宜普及的中药减少北京本土发病人数、治愈多数症状较轻的甲流患者、减少重症病例及降低死亡率,以及解决达菲的副作用、耐药性、储备量不足、储存期限有限等等问题,按照实验室及临床治疗筛选出的中成药品种调整了我市中药储备品种目录,把科学的、安全的、疗效显著的中成药品种进行了储备,使市政府面对大流行时有充足的中医药储备。

  中医药治疗甲流的效果

  由北京地坛医院、佑安医院开展的甲型H1N1流感的临床研究证实:通过临床专家遴选的中药处方及部分中成药的功能主治,与甲型H1N1流感病机、证候特点及基本治法相吻合,具有广泛的临床应用基础。甲型H1N1流感可分为风热犯卫和热毒袭肺两个证候,单纯以经过遴选的中药进行治疗,即能够改善发热、咽痛、咳嗽等症状:退热时间平均为1.5天,咳嗽消失时间平均为4.6天,咽痛消失时间平均为3.6天,病毒核酸阴转时间平均为6.0天;在常规用药剂量范围内,未发现毒副作用和不良反应,所医治病例全部治愈出院。

  中医药治疗甲流的结论

  基础研究从治疗感冒、流感、SARS、禽流感和政府此次公布的甲型H1N1流感诊疗方案所涉及的中药处方及部分中成药共计40多种,进行了筛选和比较研究,结果证实:

  ——中药处方及部分中成药对甲型H1N1流感病毒流行株所致的小鼠肺炎死亡保护具有显著作用;

  ——中药处方及部分中成药同时具有解热作用,能改善发热症状;

  ——中药处方及部分中成药对多毒株所致肺炎模型有效,可在季节性流感大流行尚未分型时早期辨证使用。

  中医药治疗甲流的证据

  5月,地坛医院第一时间请中医专家介入甲型H1N1流感确诊病例的治疗,地坛医院和佑安医院两家定点收治医院又进一步探索对确诊病例的纯中医药治疗。至9月1日,在收治的845例甲型H1N1流感确诊病例中,采用纯中药治疗的有326例。实践证明,中医以及中西医结合治疗甲型H1N1流感均具有很好的疗效。

  科研先行,“防治甲型H1N1流感有效中药筛选及评价研究”和“甲型H1N1流感抗病毒与中药治疗的多中心、前瞻、随机对照研究”两大科技攻关专项,将从证据医学上解决“中医药是否有效”、“如何选择中药”和“如何储备中药”等关键问题。A stream of Chinese medicine treatment of the exact effect of the city government 70 million people bought 2 million copies of reserve medicine http://www.sina.com.cn 2009 Nian 09 Yue 18 Ri 13:10 Beijing Evening News
GUAN Chun-fang Wei Qiang LIU Yan-ling / text

 
 


WASHINGTON Facing global outbreak of Influenza A H1N1 outbreak of influenza in the face of inadequate reserves and Western medicine treatment of toxic side-effects, resistance to high world problems, after 3 months the municipal financial investment 10 million yuan project, municipal health bureau, Chinese medicine Council, led by the China Academy of Traditional Chinese Medicine, Chinese Academy of Medical Sciences, Beijing University of Technology, the National Influenza H1N1 influenza prevention and control of Chinese medicine expert group composed of basic and clinical groups, first in the world from basic research and clinical research both confirmed the prevention and treatment of Chinese medicine Influenza A H1N1 influenza, the efficacy and safety, and development of effective screening of Chinese herbs, made East-meets-control programs.

The study was announced yesterday on the subject to achieve substantive results - in medicine to protect against pneumonia, a significant effect on the flow of high fever with antipyretic A effect on the strain caused pneumonia in more than curative. According to preliminary research results, the Beijing municipal government has decided to readjust the government's drug prevention and control of Influenza A H1N1 influenza reserves catalog, the municipal government invested 70 million yuan, the original reserves of 100 million people in the planned bulk drugs Tamiflu reserves were adjusted to 2 million people were reserves related to Chinese medicine.

Zhao Jing, Beijing Traditional Chinese Medicine Administration Bureau, said:

Proved to the world of scientific

Chinese medicine can fight the epidemic

Integration of the capital city's most traditional Chinese medicine, Western medicine, medicine, and animal experiments scientific and technological resources, after nearly three months to explore the Chinese Medicine to Combat Influenza H1N1 influenza efforts, the project has achieved results, in response to a pandemic, to carry out scientific Chinese medicine to prevent, to conduct scientific and rational medicine reserves, home of Chinese medicine in patients with mild treatment in patients with severe combined Chinese and Western treatment, securing the capital, have come rather late peak of the epidemic, the epidemic caused by the change of the social turmoil smaller, fewer cases of severe illness and death that, in time for a possible pandemic influenza outbreak, be able to confirm to the world of scientific data on influenza A H1N1 influenza prevention and control of Chinese medicine is safe and effective, providing a scientific basis.

TCM clinical and scientific research, the preliminary results, in response to autumn and winter influenza pandemic Pieces of Chinese medicine and Chinese medicine reserves to provide a scientific basis. We deal with possible flu virus mutates and pandemic influenza, in order to use cheap, safe and popular Chinese medicine should reduce the local incidence of Beijing, cure most of the symptoms of a mild flow of patients, to reduce cases of severe disease and lower mortality, as well as the resolve Tamiflu side effects, drug resistance, lack of reserves, storage of limited duration and so on, according to laboratory and clinical treatment of selected varieties of proprietary Chinese medicines adjusted the city's reserve of varieties of Chinese medicine directory, the scientific, safety, efficacy significantly of proprietary Chinese medicines varieties of reserves, so that the face of a pandemic when the city government have sufficient reserves of Chinese medicine.

A stream of Chinese medicine treatment of the effect of

By the Beijing Ditan Hospital, You'an Hospital carried out in clinical studies influenza A H1N1 influenza confirmed: the selection of Chinese medicine through clinical experts, and some proprietary Chinese medicine prescriptions Indication, and influenza A H1N1 influenza pathogenesis, characteristics and the basic rule Syndrome wears fit with extensive clinical application base. Influenza A H1N1 influenza can be divided into wind-heat and thermal drug offenders Wei lung passage of two syndromes, simply through the selection of traditional Chinese medicine to treat, that is, to improve fever, sore throat, cough and other symptoms: fever average of 1.5 days, The average time for cough disappeared 4.6 days, sore throat and lost an average of 3.6 days, the virus nucleic acid overcast average of 6.0 days; in the context of conventional dosage was not found toxic side effects and adverse reactions, the treatment of all patients discharged from hospital .

A Stream of the conclusions of medical treatment

Basic research from the treatment of colds, influenza, SARS, avian flu and the government announced the program of Influenza A H1N1 flu clinics involved in some traditional Chinese medicine prescription and a total of more than 40 kinds of Chinese medicine, were screened and compared their findings confirm that:

- Prescription and some of the proprietary Chinese medicine for influenza pandemic strains of H1N1 influenza virus pneumonia in mice caused by the death to protect a significant role;

- Prescription and some of the proprietary Chinese medicine also has antipyretic effects, can improve symptoms of fever;

- Part of the proprietary Chinese medicine prescription and pneumonia caused by multi-strain model for effective, seasonal influenza pandemic has not yet dialectical use of genotyping at an early stage.

A stream of evidence of medical treatment

May, Ditan Hospital, the first time invited Chinese experts to participate in confirmed cases of Influenza A H1N1 influenza treatment, Ditan Hospital and admitted to the hospital designated You'an Hospital two further exploration of the confirmed cases of pure Chinese medicine treatment. Until September 1, in 845 cases admitted to influenza H1N1 confirmed cases of influenza, the use of pure traditional Chinese medicine there are 326 cases. Practice has proved that Chinese and Western medicine with traditional Chinese medicine as well as the treatment of Influenza A H1N1 influenza all have good results.

Research first, "Influenza A H1N1 influenza prevention and control of effective screening and evaluation research of Chinese medicine" and "Anti-Influenza A H1N1 influenza virus and traditional Chinese medicine treatment of multi-center, prospective, randomized controlled study," the two special science and technology research, evidence-based medicine will be resolved " Chinese medicine is effective, "" how to choose Chinese medicine "and" How to reserve traditional Chinese medicine "and other key issues.
 

 
 
 
 
 

[ 作者:佚名    转贴自:本站原创    点击数:196    更新时间:2009-9-20    文章录入:nnb ]

 

艾滋病或不再是绝症

价值中国网网友关注“发明艾滋病新药免费救治征集媒体见证人”

艾滋病早期治疗是康复与延长30~60年生命的保障

鸡尾酒疗法并非万能,抗药性与毒副作用导致联合疗法与中药疗法应用的迫切性

呼吁救治艾滋,关注化学新药

康生丹配合西药治疗AIDS总结

艾滋病“感染”、“免疫”与“营养”三关各期施治研究

康生丹四代新药,化学名—三合皂甙分类引述
 

艾滋病免疫重建的重要意义是挽救生命的根本 

从食品植物研究开发的治疗艾滋病新药三合皂甙〔康生丹四代〕介绍  

从食品植物研究开发的治疗艾滋病新药三合皂甙  

从食品植物研究开发的治疗艾滋病新药介绍  

艾滋病的中药  

论HIV不是AIDS的病因机制 

康生丹颗粒简介 

美国营养学家推崇“抗炎饮食”同于中医之食疗 

康生丹颗粒基础研究 

艾滋病预防及国外食疗研究 

艾滋病感染者能活多久 

专家:艾滋病早治疗能多活30年以上“隐形”感染者进入晚期才被确诊 

T细胞、T细胞亚群、 调节性(或抑制性)T细胞在艾滋病康复中的研究 

你知道为什么害怕“艾滋病”这三个字么?艾滋病不同感染期症状 

康生丹颗粒〈ksd〉对免疫抑制模型小鼠免疫功能影响实验研究-公布 

食疗与艾滋病研究-康生丹颗粒〈一〉 

艾滋病未来康复的动向分析 

艾滋病人的药膳 

首次公布康生丹提高艾滋病患者CD4的图片